← Back to Skills Marketplace
hanxueyuan

Ipsen

by hanxueyuan · GitHub ↗ · v0.1.0 · MIT-0
cross-platform ✓ Security Clean
52
Downloads
0
Stars
0
Active Installs
1
Versions
Install in OpenClaw
/install ipsen
Description
Ipsen is a French biopharma specializing in oncology, rare diseases, and neuroscience with a focused portfolio and global presence including a key botulinum...
README (SKILL.md)

Ipsen

Overview

Ipsen is a French biopharmaceutical company specializing in oncology, rare diseases, and neuroscience, with a focused portfolio approach that differentiates it from big pharma diversification.

Historical Timeline

  • 1929: Founded as a small French pharmaceutical company
  • 1990s: Focuses on endocrinology and oncology specialties
  • 2010: Launches Dysport (botulinum toxin) in US market
  • 2019: Acquires Clementia Pharmaceuticals for $1.2B (fibrodysplasia drug)
  • 2022: Revenue reaches €3.1B; oncology portfolio drives growth
  • 2024: Announces major investment in radiopharmaceutical oncology

Business Model

Three therapeutic areas: Oncology (45% — Cabometyx, Onureg), Rare Disease (30% — Dysport, Somatuline), and Neuroscience (25% — Nuplazid). Revenue from prescription drug sales globally, with strong US presence through partnerships and direct sales force.

Moat Analysis

Focused portfolio in high-growth therapeutic areas (oncology, rare diseases) means deeper expertise than diversified competitors. Botulinum toxin franchise (Dysport) competes directly with Allergan's Botox. European headquarters provides advantageous pricing and regulatory environment.

Key Data

  • revenue: ~€3.3B (2023)
  • market_cap: ~€8B
  • r_and_d: ~15% of revenue
  • employees: ~6,600
  • countries: ~120

Interesting Facts

  • Ipsen's Dysport is one of only four botulinum toxin products approved by the FDA — competing directly with Botox in a $6B+ market.
  • Despite being much smaller than Big Pharma, Ipsen's oncology revenue per employee exceeds that of several major pharmaceutical companies.
Usage Guidance
This skill is low-risk from a security perspective because it is instruction-only, contains static content, and requests no credentials or installs. You may still want to verify any factual claims (revenues, dates, product counts) against authoritative sources before using the information operationally. Because the skill's source/homepage is 'unknown', treat it as an unverified summary rather than an official company document.
Capability Analysis
Type: OpenClaw Skill Name: ipsen Version: 0.1.0 The skill bundle contains purely informational content regarding Ipsen, a biopharmaceutical company. It consists of a metadata file and a markdown file (SKILL.md) providing historical data, business analysis, and key facts. There is no executable code, network activity, or suspicious instructions present.
Capability Assessment
✓ Purpose & Capability
Name and description match the SKILL.md content (company overview, timeline, business model). The skill requests no binaries, env vars, or config paths — which is appropriate for a read-only informational skill.
✓ Instruction Scope
SKILL.md contains only static company information and 'read_when' contexts. It does not instruct the agent to read local files, access environment variables, call external endpoints, or transmit data elsewhere.
✓ Install Mechanism
No install specification or code files are present; this minimizes surface area since nothing is written to disk or downloaded during installation.
✓ Credentials
The skill declares no required environment variables, credentials, or config paths. There is no disproportionate credential request for the stated purpose.
✓ Persistence & Privilege
always is false and the skill is user-invocable (normal defaults). It does not request persistent privileges or attempt to modify other skills or system settings.
How to Use
  1. Make sure OpenClaw is installed (local or Docker)
  2. Run the install command in chat: /install ipsen
  3. After installation, invoke the skill by name or use /ipsen
  4. Provide required inputs per the skill's parameter spec and get structured output
Version History
v0.1.0
Initial publish: French biopharmaceutical company
Metadata
Slug ipsen
Version 0.1.0
License MIT-0
All-time Installs 0
Active Installs 0
Total Versions 1
Frequently Asked Questions

What is Ipsen?

Ipsen is a French biopharma specializing in oncology, rare diseases, and neuroscience with a focused portfolio and global presence including a key botulinum... It is an AI Agent Skill for Claude Code / OpenClaw, with 52 downloads so far.

How do I install Ipsen?

Run "/install ipsen" in the OpenClaw or Claude Code chat to install it in one step — no extra setup required.

Is Ipsen free?

Yes, Ipsen is completely free, licensed under MIT-0. You can download, install and use it at no cost.

Which platforms does Ipsen support?

Ipsen is cross-platform and runs anywhere OpenClaw / Claude Code is available (cross-platform).

Who created Ipsen?

It is built and maintained by hanxueyuan (@hanxueyuan); the current version is v0.1.0.

More Skills
self-improving agent
Captures learnings, errors, and corrections to enable continuous improvement. Use when: (1) A command or operation fails unexpectedly, (2) User corrects Clau...
⬇ 463283 · by pskoett
Skill Vetter
Security-first skill vetting for AI agents. Use before installing any skill from ClawdHub, GitHub, or other sources. Checks for red flags, permission scope, and suspicious patterns.
⬇ 259410 · by spclaudehome
Polymarket
Query Polymarket prediction markets. Check odds, find trending markets, search events, track price movements.
⬇ 232503 · by joelchance
Self-Improving + Proactive Agent
Self-reflection + Self-criticism + Self-learning + Self-organizing memory. Agent evaluates its own work, catches mistakes, and improves permanently. Use when...
⬇ 200423 · by ivangdavila
Github
Interact with GitHub using the `gh` CLI. Use `gh issue`, `gh pr`, `gh run`, and `gh api` for issues, PRs, CI runs, and advanced queries.
⬇ 191115 · by steipete
ontology
Typed knowledge graph for structured agent memory and composable skills. Use when creating/querying entities (Person, Project, Task, Event, Document), linkin...
⬇ 190156 · by oswalpalash

💬 Comments